Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow-to-Debt Ratio
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of CN¥227.64 Million could theoretically repay 0% of its total liabilities (CN¥2.29 Billion) in one year. Explore 002020 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Zhejiang Jingxin Pharmaceutical Co Ltd across 24 annual periods. Also explore 002020 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Zhejiang Jingxin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 002020 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.35x | CN¥781.35 Million | CN¥2.25 Billion | ▲ +18.3% |
| 2024 | 0.29x | CN¥726.16 Million | CN¥2.48 Billion | ▼ -13.1% |
| 2023 | 0.34x | CN¥824.69 Million | CN¥2.45 Billion | ▼ -13.7% |
| 2022 | 0.39x | CN¥855.78 Million | CN¥2.19 Billion | ▲ +68.9% |
| 2021 | 0.23x | CN¥365.02 Million | CN¥1.58 Billion | ▼ -21.8% |
| 2020 | 0.30x | CN¥513.21 Million | CN¥1.73 Billion | ▲ +5.9% |
| 2019 | 0.28x | CN¥535.30 Million | CN¥1.91 Billion | ▼ -24.2% |
| 2018 | 0.37x | CN¥523.40 Million | CN¥1.42 Billion | ▼ -10.1% |
| 2017 | 0.41x | CN¥385.01 Million | CN¥938.43 Million | ▲ +40.3% |
| 2016 | 0.29x | CN¥252.69 Million | CN¥864.23 Million | ▲ +37.3% |
| 2015 | 0.21x | CN¥144.69 Million | CN¥679.39 Million | ▼ -32.6% |
| 2014 | 0.32x | CN¥210.49 Million | CN¥666.12 Million | ▲ +44.2% |
| 2013 | 0.22x | CN¥111.03 Million | CN¥506.65 Million | ▲ +92.1% |
| 2012 | 0.11x | CN¥60.28 Million | CN¥528.40 Million | ▼ -29.9% |
| 2011 | 0.16x | CN¥69.41 Million | CN¥426.39 Million | ▲ +72.0% |
| 2010 | 0.09x | CN¥59.55 Million | CN¥629.02 Million | ▼ -57.3% |
| 2009 | 0.22x | CN¥135.38 Million | CN¥610.06 Million | ▲ +381.0% |
| 2008 | 0.05x | CN¥29.98 Million | CN¥649.89 Million | ▲ +137.7% |
| 2007 | -0.12x | CN¥-87.60 Million | CN¥716.18 Million | ▼ -3945.1% |
| 2006 | 0.00x | CN¥-1.45 Million | CN¥478.23 Million | ▼ -101.4% |
| 2005 | 0.22x | CN¥61.82 Million | CN¥279.27 Million | ▲ +523.5% |
| 2004 | 0.04x | CN¥6.43 Million | CN¥181.11 Million | ▼ -86.9% |
| 2003 | 0.27x | CN¥46.18 Million | CN¥170.36 Million | ▼ -28.9% |
| 2002 | 0.38x | CN¥45.50 Million | CN¥119.35 Million | — |